From illuminating public buildings in red to candlelight vigils and walks, supporters are gearing up to raise awareness and increase public knowledge about sickle cell disease (SCD) on June 19, World Sickle Cell Day. This year’s global theme is “Global Action, Local Impact: Empowering Communities for Effective Self-Advocacy.” SCD…
News
BEAM-101, a genetically modified cell therapy for sickle cell disease (SCD) that’s being tested in clinical trials, has been granted orphan drug status by the U.S. Food and Drug Administration (FDA). The FDA gives the designation to experimental therapies designed to treat conditions that affect fewer than 200,000 people…
The U.S. Food and Drug Administration has granted orphan drug status to Sanofi’s rilzabrutinib, an investigational therapy aimed at preventing painful vaso-occlusive crises (VOCs) in people with sickle cell disease (SCD). This designation intends to encourage companies to develop therapies for rare diseases, or those affecting fewer…
An algorithm that grew out of a collaboration between different specialties at the Medical University of South Carolina (MUSC) may help reduce unnecessary hospital admissions for children with sickle cell disease (SCD), according to a new study. “This algorithm safely allows our care of these patients to align with…
Adolescents and young adults with sickle cell disease (SCD) may face challenges in accessing physical therapy that could help them manage symptoms, a study reports. While young people with poorer quality-of-life metrics tended to receive more referrals to physical therapists, this did not translate to more physical therapy visits…
Meningitis — an inflammation of the protective membranes surrounding the brain and spinal cord — remains associated with a case-fatality rate of nearly 30% in children with sickle cell disease (SCD), according to the findings of a new two-decade study from France. This is despite vaccinations for SCD children…
Many adolescents with sickle cell disease (SCD) aren’t having recommended depression screenings nor regularly visiting their primary care providers (PCPs), even though most have a registered PCP, a study reports. “Despite a higher overall rate of depression in this population … most youth are not being screened for depression…
A program that provides integrated primary and specialist care for adults with sickle cell disease (SCD) significantly reduced emergency department visits, according to a study from Massachusetts General Hospital. “Our Comprehensive Sickle Cell Disease Center (CSCDC) is one of few comprehensive adult care models that integrates [primary care physicians]…
Sickle cell disease (SCD) and sickle cell trait (SCT) can increase the risk of eye diseases associated with diabetes mellitus, according to a recent study. Findings indicated patients who had diabetes along with SCT or SCD were more likely to have procedures to treat eye disease and poorer overall…
Top-line data from the Phase 3 part of RISE UP, a clinical trial testing mitapivat in people with sickle cell disease (SCD), are expected by the end of the year, according to developer Agios Pharmaceuticals. If those results are positive and mitapivat wins regulatory approval for SCD, it…
Recent Posts
- Bias in sickle cell care may be tied to opioid stigma, new study finds
- How I advocate for my health needs while traveling for work
- Brain development changes seen in children with sickle cell anemia
- Beam to seek OK of gene-edited cell therapy risto-cel for sickle cell disease
- Agios to seek accelerated approval in US of oral mitapivat for SCD
- Japanese agency awards $32M to advance sickle cell treatment to trials
- Intentional lifestyle changes got me through winter without a crisis
- Chicago nurses lead charge to speed up SCD emergency care: Study
- Recognizing the warning signs and symptoms of a sickle cell crisis
- US senators seek 5 more years of federal funding for stem cell program